OBALON THERAPEUTICS INC (65) | Warrant Agreements (17)
Recent Contracts
-
Form of Common Warrant
(Filed With SEC on February 3, 2023)
-
Form of Warrant Agency Agreement between ReShape and American Stock Transfer & Trust Company, LLC
(Filed With SEC on January 27, 2023)
-
Form of Underwriters Warrant
(Filed With SEC on January 27, 2023)
-
Form of Pre-Funded Warrant
(Filed With SEC on January 27, 2023)
-
Form of Common Warrant
(Filed With SEC on January 27, 2023)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on November 14, 2022)
-
Form of Warrant Amendment Agreement, dated November 8, 2022, by and between ReShape Lifesciences Inc. and the Investor
(Filed With SEC on November 14, 2022)
-
Form of Pre-funded Warrant
(Filed With SEC on November 14, 2022)
-
Warrant Exercise Agreement, dated June 16, 2022, by and among ReShape Lifesciences Inc. and the investor party thereto
(Filed With SEC on June 23, 2022)
-
Form of New Warrant
(Filed With SEC on June 23, 2022)
-
Form of New Warrant
(Filed With SEC on July 19, 2021)
-
Warrant Exercise Agreement, dated June 28, 2021, by and among ReShape Lifesciences Inc. and the purchasers party thereto
(Filed With SEC on July 2, 2021)
-
Form of New Warrant
(Filed With SEC on July 2, 2021)
-
Form of Warrant
(Filed With SEC on August 14, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on August 1, 2019)
-
Form of Warrant Agent Agreement between Obalon Therapeutics, Inc. and American Stock Transfer & Trust Company, LLC
(Filed With SEC on August 1, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on August 1, 2019)